Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices
Market Cap
$513.08 Million
CN¥3.76 Billion CNY
Market Cap Rank
#13381 Global
#3444 in China
Share Price
CN¥6.92
Change (1 day)
+1.62%
52-Week Range
CN¥4.07 - CN¥11.33
All Time High
CN¥23.05
About

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more

Beijing Leadman Biochemistry Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 15.53%

Beijing Leadman Biochemistry Co Ltd (300289) has an Asset Resilience Ratio of 15.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥281.00 Million
Cash + Short-term Investments
Total Assets
CN¥1.81 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Beijing Leadman Biochemistry Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Beijing Leadman Biochemistry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥281.00 Million 15.53%
Total Liquid Assets CN¥281.00 Million 15.53%

Asset Resilience Insights

  • Good Liquidity Position: Beijing Leadman Biochemistry Co Ltd maintains a healthy 15.53% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Beijing Leadman Biochemistry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Leadman Biochemistry Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
FluroTech Ltd
OTCQB:FLURF
Medical Devices 0.00%
DRGEM Corporation
KQ:263690
Medical Devices 0.50%
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%

Annual Asset Resilience Ratio for Beijing Leadman Biochemistry Co Ltd (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Leadman Biochemistry Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 17.35% CN¥316.14 Million CN¥1.82 Billion +2.37pp
2023-12-31 14.98% CN¥290.29 Million CN¥1.94 Billion --
pp = percentage points